Y-Intercept (HK)’s Zenas BioPharma ZBIO Stock Holding History

Y-Intercept (HK)’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440K	Buy	+17,332	New	+$345K	0.01%	1347

Other funds holding ZBIO

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return

Y-Intercept (HK)'s ZBIO Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Zenas BioPharma (ZBIO) in Q2 2026: 17,332 shares worth $440K. The stake represents 0.01% of the portfolio and ranks #1347 among its holdings.

9 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

Y-Intercept (HK) held 17,332 shares of Zenas BioPharma worth $440K as of Q2 2026.
Zenas BioPharma was a new Y-Intercept (HK) position in Q2 2026.
Zenas BioPharma made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1347 holding.
9 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.